165 related articles for article (PubMed ID: 26327203)
1. Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.
Pires ES; D'Souza RS; Needham MA; Herr AK; Jazaeri AA; Li H; Stoler MH; Anderson-Knapp KL; Thomas T; Mandal A; Gougeon A; Flickinger CJ; Bruns DE; Pollok BA; Herr JC
Oncotarget; 2015 Oct; 6(30):30194-211. PubMed ID: 26327203
[TBL] [Abstract][Full Text] [Related]
2. SAS1B protein [ovastacin] shows temporal and spatial restriction to oocytes in several eutherian orders and initiates translation at the primary to secondary follicle transition.
Pires ES; Hlavin C; Macnamara E; Ishola-Gbenla K; Doerwaldt C; Chamberlain C; Klotz K; Herr AK; Khole A; Chertihin O; Curnow E; Feldman SH; Mandal A; Shetty J; Flickinger C; Herr JC
Dev Dyn; 2013 Dec; 242(12):1405-26. PubMed ID: 24038607
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer.
Knapp KA; Pires ES; Adair SJ; Mandal A; Mills AM; Olson WC; Slingluff CL; Parsons JT; Bauer TW; Bullock TN; Herr JC
Oncotarget; 2018 Feb; 9(10):8972-8984. PubMed ID: 29507667
[TBL] [Abstract][Full Text] [Related]
4. Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates.
Mandal A; Shetty J; Tran CA; Olson WC; Mandal M; Ban B; Pires ES; Adair SJ; Bauer TW; Slingluff CL; Herr JC
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38485187
[TBL] [Abstract][Full Text] [Related]
5. Oocyte specific oolemmal SAS1B involved in sperm binding through intra-acrosomal SLLP1 during fertilization.
Sachdev M; Mandal A; Mulders S; Digilio LC; Panneerdoss S; Suryavathi V; Pires E; Klotz KL; Hermens L; Herrero MB; Flickinger CJ; van Duin M; Herr JC
Dev Biol; 2012 Mar; 363(1):40-51. PubMed ID: 22206759
[TBL] [Abstract][Full Text] [Related]
6. Intracellular activation of ovastacin mediates pre-fertilization hardening of the zona pellucida.
Körschgen H; Kuske M; Karmilin K; Yiallouros I; Balbach M; Floehr J; Wachten D; Jahnen-Dechent W; Stöcker W
Mol Hum Reprod; 2017 Sep; 23(9):607-616. PubMed ID: 28911209
[TBL] [Abstract][Full Text] [Related]
7. Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.
Pires ES; D'Souza RS; Needham MA; Herr AK; Jazaeri AA; Li H; Stoler MH; Anderson-Knapp KL; Thomas T; Mandal A; Gougeon A; Flickinger CJ; Bruns DE; Pollok BA; Herr JC
Oncotarget; 2017 Feb; 8(9):16099. PubMed ID: 28403580
[No Abstract] [Full Text] [Related]
8. Monoclonal antibody 7H2.2 binds the C-terminus of the cancer-oocyte antigen SAS1B through the hydrophilic face of a conserved amphipathic helix corresponding to one of only two regions predicted to be ordered.
Legg MSG; Gagnon SML; Powell CJ; Boulanger MJ; Li AJJ; Evans SV
Acta Crystallogr D Struct Biol; 2022 May; 78(Pt 5):623-632. PubMed ID: 35503210
[TBL] [Abstract][Full Text] [Related]
9. The detection of SAS1B in serum provides clues for early diagnosis of thyroid cancer.
Yang HX; Yang Y; Li XD; Miao XM; Yang C; Zhi DF; Su H; Yang G; Gao J; Du CG; Li HJ; Song YL; Cao GF
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1410-1424. PubMed ID: 33629311
[TBL] [Abstract][Full Text] [Related]
10. Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives.
Vitale SG; Laganà AS; Capriglione S; Angioli R; La Rosa VL; Lopez S; Valenti G; Sapia F; Sarpietro G; Butticè S; Tuscano C; Fanale D; Tropea A; Rossetti D
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531111
[TBL] [Abstract][Full Text] [Related]
11. High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.
Ha KD; Bidlingmaier SM; Zhang Y; Su Y; Liu B
Mol Cell Proteomics; 2014 Dec; 13(12):3320-31. PubMed ID: 25149096
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the liver-derived plasma protein fetuin-B mediates reversible female infertility.
Floehr J; Dietzel E; Schmitz C; Chappell A; Jahnen-Dechent W
Mol Hum Reprod; 2017 Jan; 23(1):34-44. PubMed ID: 27733488
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
[TBL] [Abstract][Full Text] [Related]
14. The novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines.
Lund K; Bostad M; Skarpen E; Braunagel M; Kiprijanov S; Krauss S; Duncan A; Høgset A; Selbo PK
MAbs; 2014; 6(4):1038-50. PubMed ID: 24525727
[TBL] [Abstract][Full Text] [Related]
15. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of immunotoxin by antibody to ganglioside GD3: a novel drug delivery route for tumor cells.
Torres Demichelis V; Vilcaes AA; Iglesias-Bartolomé R; Ruggiero FM; Daniotti JL
PLoS One; 2013; 8(1):e55304. PubMed ID: 23383146
[TBL] [Abstract][Full Text] [Related]
17. Role of p53 pathway alterations in uterine carcinosarcomas (malignant mixed Müllerian tumors).
Semczuk A; Ignatov A; Obrzut B; Reventos J; Rechberger T
Oncology; 2014; 87(4):193-204. PubMed ID: 25033979
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a cell line, MT-213-VGH, isolated from a mixed müllerian tumor of the uterus.
Chao KC; Wang PH; Chang CC; Lai CR; Ng HT
Acta Cytol; 2001; 45(5):683-90. PubMed ID: 11575644
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of cell lines derived from uterine malignant mixed Müllerian tumor.
Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
Gynecol Oncol; 1997 Sep; 66(3):464-74. PubMed ID: 9299262
[TBL] [Abstract][Full Text] [Related]
20. Polysomy 8 in three cases of homologous malignant mixed Müllerian tumors of the uterus.
Gunawan B; Baumhoer D; Schulten HJ; Emons G; Füzesi L
Anticancer Res; 2003; 23(2B):1379-83. PubMed ID: 12820397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
